Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Net Margin (2023 - 2024)

Praxis Precision Medicines (PRAX) has 2 years of Net Margin data on record, last reported at 856.97% in Q4 2024.

  • For Q4 2024, Net Margin rose 454225.0% year-over-year to 856.97%; the TTM value through Sep 2025 reached 3927.51%, up 629149.0%, while the annual FY2024 figure was 2340.29%, 282412.0% up from the prior year.
  • Net Margin reached 856.97% in Q4 2024 per PRAX's latest filing, up from 18819.54% in the prior quarter.
  • Across five years, Net Margin topped out at 856.97% in Q4 2024 and bottomed at 18819.54% in Q3 2024.